Potential Treatment Options for COVID-19 Medication Chart – See chart
NIH Registered Clinical Trials
Simulation of Risk of Adverse Drug Events Associated with the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy – Read more
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations – Read more
TRHC’s CareKinesis® COVID-19 resource for PACE page includes information on the coronavirus and COVID-19, including test kits, BioIntelliSense BioStickers™, potential treatment options, webinars, and potential COVID-19 treatment options, and clinical studies.
TRHC’s PrescribeWellness™ coronavirus webpage includes quick links for pharmacies, including an online order form for COVID-19 test kits, as well as timely collated updates generated from venerable sources such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
Access TRHC’s webinar about the risks associated with COVID-19 treatment, particularly with vulnerable individuals who have several chronic diseases and take multiple medications. View recorded webinar >
During the COVID-19 pandemic, staying healthy is top of mind. For individuals at risk for or diagnosed with COVID-19, the addition of new treatments may pose another medical danger: adverse drug events (ADEs). ADEs cause an estimated 150,000 deaths per year in the United States and 1.3 million emergency room visits, resulting in nearly 350,000 people hospitalized for further treatment.